Hospital
Paulding County Hospital
Paulding County Hospital was paid $2.77M by Medicaid between Jan 2018 and Dec 2024, across 85 billing codes. Its largest line is 99283, emergency room visit (moderate) — 31% of everything it billed.
33Billing provider infoPAULDING COUNTY HOSPITAL
PAULDING, OH 45879
PAULDING, OH 45879
33aNPI1144298514assigned 03/10/2006
33bProvider typeCritical Access Hospital
28Total paid$2.77M
24GClaims59,019
24DCodes billed85
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Critical Access Hospital providers in Ohio
Rank by total paid#23 of 26
Median peer was paid$5.33M
This provider vs. median0.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 4,494 | $115K | |
| 2019 | 3,292 | $86K | |
| 2020 | 3,497 | $174K | |
| 2021 | 3,331 | $188K | |
| 2022 | 3,949 | $262K | |
| 2023 | 24,922 | $1.14M | |
| 2024incomplete | 15,534 | $804K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 31% | 5,352 | 4,723 | $848K |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 2,119 | 1,792 | $316K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 9.9% | 1,185 | 793 | $275K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 9.7% | 2,760 | 670 | $267K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 6.4% | 409 | 271 | $176K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.0% | 371 | 297 | $137K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.4% | 640 | 483 | $94K |
| 80053 | Comprehensive metabolic panel | 2.8% | 3,811 | 3,189 | $77K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 2.6% | 1,241 | 903 | $72K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.5% | 1,121 | 354 | $68K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.6% | 111 | 90 | $43K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.3% | 6,742 | 5,140 | $36K |
73 more codes
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 1.2% | 350 | $33K |
| 84443 | Thyroid stimulating hormone (TSH) | 1.1% | 977 | $31K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.0% | 168 | $28K |
| 80061 | Lipid panel | <1% | 1,007 | $21K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 1,142 | $21K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 309 | $20K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 122 | $19K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,610 | $19K |
| 87631 | <1% | 80 | $16K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 567 | $14K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,407 | $13K |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,941 | $13K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 153 | $12K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 285 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 29 | $10K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 76 | $7K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,304 | $7K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 570 | $6K |
| J3490 | Unclassified drugs | <1% | 910 | $5K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 187 | $5K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 710 | $4K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 643 | $4K |
| 81001 | <1% | 2,547 | $3K | |
| 71045 | Radiologic examination, chest; single view | <1% | 816 | $3K |
| 82728 | <1% | 75 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 708 | $2K |
| G0378 | Hospital observation service, per hour | <1% | 52 | $2K |
| 83735 | <1% | 438 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 12 | $2K |
| 97161 | <1% | 15 | $2K | |
| 84484 | <1% | 966 | $2K | |
| 82570 | <1% | 131 | $2K | |
| 82550 | <1% | 779 | $2K | |
| 86140 | <1% | 34 | $1K | |
| 83540 | <1% | 78 | $1K | |
| 82607 | <1% | 33 | $1K | |
| 87186 | <1% | 195 | $1K | |
| 83690 | <1% | 811 | $1K | |
| 83605 | <1% | 734 | $1K | |
| 87040 | <1% | 487 | $979.49 | |
| 84439 | <1% | 25 | $959.29 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 288 | $865.74 |
| 0001A | <1% | 37 | $795.50 | |
| 0002A | <1% | 29 | $737.29 | |
| 83550 | <1% | 58 | $719.57 | |
| 82043 | <1% | 37 | $589.03 | |
| 87070 | <1% | 15 | $584.34 | |
| 87088 | <1% | 119 | $504.38 | |
| E0570 | Nebulizer, with compressor | <1% | 76 | $497.51 |
| 80305 | <1% | 52 | $467.90 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,690 | $311.63 |
| 85610 | <1% | 146 | $288.85 | |
| 82150 | <1% | 61 | $284.45 | |
| 82248 | <1% | 329 | $279.75 | |
| 85652 | <1% | 15 | $175.43 | |
| 81025 | <1% | 105 | $83.76 | |
| 87634 | <1% | 36 | $64.64 | |
| 82553 | <1% | 44 | $48.18 | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 659 | $24.76 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 399 | $21.71 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 66 | $19.56 |
| 85379 | <1% | 40 | $18.68 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 579 | $17.17 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 306 | $13.36 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 332 | $0.73 |
| 91300 | <1% | 35 | $0.26 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 325 | $0.00 |
| 93041 | 0% | 34 | $0.00 | |
| 85730 | 0% | 60 | $0.00 | |
| A9270 | Non-covered item or service | 0% | 633 | $0.00 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | 0% | 31 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 22 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 16 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialGOEDDE, RONALD (CEO)